Moderna, Inc.
MRNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,074 | $10,705 | $10,943 | $16,008 |
| - Cash | $1,132 | $1,279 | $1,623 | $1,927 |
| + Debt | $734 | $741 | $745 | $747 |
| Enterprise Value | $9,676 | $10,167 | $10,065 | $14,828 |
| Revenue | $1,016 | $142 | $107 | $956 |
| % Growth | 615.5% | 32.7% | -88.8% | – |
| Gross Profit | $8 | $23 | $17 | $217 |
| % Margin | 0.8% | 16.2% | 15.9% | 22.7% |
| EBITDA | -$135 | -$760 | -$924 | -$1,118 |
| % Margin | -13.3% | -535.2% | -863.6% | -116.9% |
| Net Income | -$200 | -$825 | -$971 | -$1,120 |
| % Margin | -19.7% | -581% | -907.5% | -117.2% |
| EPS Diluted | -0.51 | -2.13 | -2.52 | -2.91 |
| % Growth | 76.1% | 15.5% | 13.4% | – |
| Operating Cash Flow | -$847 | -$919 | -$1,037 | $825 |
| Capital Expenditures | -$33 | -$3 | -$127 | -$522 |
| Free Cash Flow | -$880 | -$922 | -$1,164 | $303 |